Maximus, Inc. (NYSE:MMS) Director Jan Madsen Sells 2,439 Shares

Maximus, Inc. (NYSE:MMS) Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now owns 18,097 shares of the company’s stock, valued at approximately $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Maximus Stock Performance

MMS opened at $67.12 on Friday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The company has a market cap of $3.80 billion, a PE ratio of 14.43 and a beta of 0.71. The stock has a 50-day moving average of $71.27 and a 200-day moving average of $78.81. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97.

Maximus (NYSE:MMS) last announced its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, equities research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.79%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a report on Thursday, January 2nd.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. UMB Bank n.a. grew its position in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 158 shares during the last quarter. Eastern Bank acquired a new stake in Maximus in the 4th quarter valued at approximately $29,000. V Square Quantitative Management LLC increased its position in Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after buying an additional 180 shares during the period. R Squared Ltd bought a new position in Maximus in the 4th quarter worth approximately $54,000. Finally, IFP Advisors Inc lifted its holdings in shares of Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock worth $59,000 after buying an additional 302 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.